Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06075576 · ClinicalTrials.gov registry record

Characterization of the Central and Peripheral Wavefront Aberration Profile in Pediatric Myopic Subjects

A clinical trial, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
23
Enrollment target

NCT06075576 is a clinical trial that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 23 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06075576 has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
23 participants
Enrollment target

Study Summary

This is a 3-visit, single site, observational clinical study to evaluate the characterization of the central and peripheral wavefront aberration profiles in pediatric myopic subjects.

Interventions

  • DIAGNOSTIC_TEST Intervention

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2023-11-16
Est. Completion 2025-08-11

Sponsor

Johnson & Johnson Vision Care

142 total trials

What the Registry Record Tells You About NCT06075576

The ClinicalTrials.gov registry entry for NCT06075576 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Intervention is the first listed.

NCT06075576 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06075576 about?

NCT06075576 is a clinical study titled "Characterization of the Central and Peripheral Wavefront Aberration Profile in Pediatric Myopic Subjects". This is a 3-visit, single site, observational clinical study to evaluate the characterization of the central and peripheral wavefront aberration profiles in pediatric myopic subjects.

What is the current status of trial NCT06075576?

This trial is currently completed. The enrollment target is 23 participants. The study started on 2023-11-16. Estimated completion is 2025-08-11.

What interventions are being tested in trial NCT06075576?

The interventions under investigation include: Intervention (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06075576?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.